Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants
Clinical trial NCT05033561 · COMPLETED
Trial details
- NCT number
- NCT05033561
- Sponsor
- Fidec Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-16
- Primary completion
- 2022-05-24
- Enrollment
- 905
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.